Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

Quant Score Hamper Exxon Mobil (XOM) Rating

By Portfolio Grader
With a $340.0 billion market value, Exxon Mobil Corp (NYSE:XOM) ranks in the top decile in its industry group, Oil Gas & Consumable Fuels, and in the top decile of sector group, Energy, in market value. From the prospective of investment attractiveness, The current Portfolio Grader ranking for XOM puts it 157 among the 290 companies in this industry group, which is a below-average position; in the top half of the sector with a ranking of 181 among the 363 companies in the sector, and number 2,717 in the nearly 5,000 company Portfolio Grader universe.

Johnson & Johnson (JNJ) a Buy on Strong Quant Score

By Portfolio Grader
Currently, Johnson & Johnson Co (NYSE:JNJ) has a Buy using the methodology for investing of Louis Navellier and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for 8 months.

Flopping Earnings Visibility Make Quality Systems (QSII) a Sell

By Portfolio Grader
Currently, Quality Systems Inc (NASDAQ:QSII) has a Sell using the approach of Louis Navellier for investing and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for the last month.

Quant Score Analytics Keep HMS Holdings (HMSY) a Strong Sell

By Portfolio Grader
With a $1.4 billion market value, HMS Holdings Corp (NASDAQ:HMSY) ranks in the top half of its industry group, Health Care Technology, and in the upper half of its sector group, Health Care, in market value. From the viewpoint of investment attractiveness, the stock's current Portfolio Grader ranking places it 24 among the 24 companies in this industry group, a position that is well below-average; squarely in the bottom quartile of the sector with a ranking of 717 among the 781 companies in the sector, and number 4,305 in the nearly 5,000 company Portfolio Grader universe.

Omnicell (OMCL) a Buy on Healthy Earnings Momentum

By Portfolio Grader
Omnicell Inc (NASDAQ:OMCL) is a $1.8 billion in market value constituent of the Health Care Technology GICS industry group where Portfolio Grader's current ranking for OMCL puts it 3 among the 24 companies in this industry group, giving it a well above-average position. OMCL is ranked in the top quartile of the sector with a ranking of 81 among the 781 companies in the sector and number 474 in the 5000 company Portfolio Grader company universe.

Inovalon Holding (INOV) a Hold on Vapid Sales Growth

By Portfolio Grader
Inovalon Holding Inc (NASDAQ:INOV) is ranked as a Hold using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing system. INOV has maintained this ranking for 3 months.

Quant Score Metrics Restrict Allscripts Healthcare Solutions (MDRX) Ratings Upgrade to Hold

By Portfolio Grader
Allscripts Healthcare Solutions (NASDAQ:MDRX) is ranked as a Hold using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. MDRX has been upgraded from a Sell to a Hold in the last week.

Cotiviti Holdings (COTV) Earnings Momentum Limit Rating

By Portfolio Grader
Currently, Cotiviti Holdings Inc (NYSE:COTV) has a Hold using the approach to investing of Louis Navellier and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for 2 months.

Industry Group Rank Restrict Medidata Solutions (MDSO) Rating

By Portfolio Grader
The current recommendation of Hold for Medidata Solutions (NASDAQ:MDSO) has been derived by using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. This represents no change from the previous week and is the same ranking MDSO has had from Portfolio Grader for 3 months.

athenahealth (ATHN) a Buy on Superior Earnings Momentum

By Portfolio Grader
athenahealth Inc (NASDAQ:ATHN) is ranked as a Buy using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing system. This represents no change from the previous week and is the same ranking ATHN has had from Portfolio Grader for the last month.

Icon (ICLR) Raised to Strong Buy from a Buy

By Portfolio Grader
Icon Plc (NASDAQ:ICLR) ranks in the upper half of its industry group, Life Sciences Tools & Services, and in the top 25% of its sector group, Health Care, with a market value of $6.3 billion. From an investment attractiveness vantage point, ICLR is ranked in the top decile of the sector with a ranking of 31 among the 781 companies in the sector; the stock's Portfolio Grader ranking places it 4 among the 32 companies in this industry group, putting in the top quartile and number 191 in the 5000 company Portfolio Grader company universe.

Vapid Quant Score Hurt Qiagen NV (QGEN) Rating

By Portfolio Grader
Currently, Qiagen NV (NASDAQ:QGEN) has a Hold using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing methodology. QGEN has recently seen its Portfolio Grader rating downgraded over the last month from a Buy to a Hold.

Bio Rad Laboratories (BIO) a Strong Buy on High-Level Quant Score

By Portfolio Grader
With a $7.6 billion market value, Bio Rad Laboratories Inc (NYSE:BIO) ranks in the upper half of its industry group, Life Sciences Tools & Services, and in the top quarter of its sector group, Health Care, in market value. From the viewpoint of investment attractiveness, the stock's current Portfolio Grader score places it 1 among the 32 companies in this industry group, positioning it among the leaders; among the sector leaders with a ranking of 10 among the 781 companies in the sector, and number 69 in the nearly 5,000 company Portfolio Grader universe.

PerkinElmer (PKI) a Buy on Healthy Earnings Growth

By Portfolio Grader
PerkinElmer Inc (NYSE:PKI) is a constituent of the 32 company Life Sciences Tools & Services GICS industry group, which is part of the 781 company GICS Health Care sector. PKI has a market value of $8.0 billion which is in the top 25% of its industry group. Currently, the stock's Portfolio Grader ranking places it 7 among the 32 companies in this industry group, placing it among the leaders; in the top quartile of the sector with a ranking of 82 among the 781 companies in the sector, and number 512 in the nearly 5,000 company Portfolio Grader universe.

Veeva Systems (VEEV) a Buy on Superior Quant Score

By Portfolio Grader
Veeva Systems Inc (NYSE:VEEV) ranks in the top decile in its industry group, Health Care Technology, and in the top quarter of its sector group, Health Care, with a market value of $8.6 billion. From an investment attractiveness vantage point, VEEV is ranked in the top quartile of the sector with a ranking of 112 among the 781 companies in the sector; Portfolio Grader's current ranking for VEEV puts it 5 among the 24 companies in this industry group, giving it a well above-average position and number 701 in the 5000 company Portfolio Grader company universe.

Waters’ (WAT) Strong Quant Score Keep it a Buy

By Portfolio Grader
Portfolio Grader currently ranks Waters Corp (NYSE:WAT) a Buy. Using Louis Navellier's investing methodology, this analytical tool assesses stocks by means of fundamental and quantitative analytical tools. This represents no change from the previous week and is the same ranking WAT has had from Portfolio Grader for the last month.

Healthy Quant Score Make Mettler-Toledo International (MTD) a Buy

By Portfolio Grader
Mettler-Toledo International Inc (NYSE:MTD) is a component of the 32 company Life Sciences Tools & Services GICS industry group, which is a segment of the 781 company GICS Health Care sector. The market value of MTD is $16.1 billion which places it in the top 25% of its industry group. Portfolio Grader's current ranking for MTD puts it 11 among the 32 companies in this industry group, placing it in the top half; in the top quartile of the sector with a ranking of 106 among the 781 companies in the sector, and number 676 in the nearly 5,000 company Portfolio Grader universe.

Cerner (CERN) a Buy on Superior Earnings Momentum

By Portfolio Grader
The current recommendation of Buy for Cerner Corp (NASDAQ:CERN) is the result of using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. CERN has recently seen its Portfolio Grader rating upgraded from a Hold to a Buy.

Superb Analytics for Earnings Momentum Make Agilent Technologies (A) a Strong Buy

By Portfolio Grader
As one of the 781 companies in the GICS Health Care sector Agilent Technologies Inc (NYSE:A) is a constituent of the 32 company Life Sciences Tools & Services GICS industry group within this sector. The market value of A is $22.2 billion which falls in the top quarter of its industry group. The stock's current Portfolio Grader score places it 3 among the 32 companies in this industry group, positioning it among the leaders; among the sector leaders with a ranking of 17 among the 781 companies in the sector, and number 127 in the nearly 5,000 company Portfolio Grader universe.
Load More Articles